Focusing on CCL2 genetic regulation as a PARP1 target, we show that PARP1 interacts with the NFκB P65 subunit, thereby maintaining transcription of CCL2. CCL2, in turn, can positively modulate PARP1 activity in cancer cells (Figure 6D). The gene discussed is RELA; the disease is cancer.